
    
      1. Determine the response rate with this regimen in an anthracycline and taxane resistant
           cohort of patients.

        2. Determine a maximum tolerated dose of capecitabine in combination with vinorelbine and
           carboplatin for this patient population.

        3. Determine the time to relapse after the administration of this regimen.
    
  